Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357. (academic.oup.com)

Authors: Taiwo BO … Tebas P Journal: Clinical Infectious Diseases Published: 2026-02-09 DOI: https://doi.org/10.1093/cid/ciaf375